ICD-10-CM 2027 diagnosis code
D68.5Primary thrombophilia
D68.5 is a header code, so it can't be reported by itself. Choose one of the 3 more specific codes beneath it.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About D68.5
D68.5 is the ICD-10-CM diagnosis code for primary thrombophilia. It belongs to category D68 (other coagulation defects), block D65-D69 (coagulation defects, purpura and other hemorrhagic conditions) and chapter 3 (diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.
Within D68 (other coagulation defects), D68.5 is specifically for primary thrombophilia. Related codes cover von Willebrand disease (D68.0), hereditary factor XI deficiency (D68.1), hereditary deficiency of other clotting factors (D68.2), hemorrhagic disorder due to circulating anticoagulants (D68.3), acquired coagulation factor deficiency (D68.4), other thrombophilia (D68.6), other specified coagulation defects (D68.8) and coagulation defect, unspecified (D68.9).
To report this condition, pick the subcode that matches the documentation: D68.51 (resistance), D68.52 (mutation) and D68.59 (thrombophilia).
Don't report D68.5 together with the conditions in its Excludes1 note: antiphospholipid syndrome (D68.61), lupus anticoagulant (D68.62), secondary activated protein C resistance (D68.69), secondary antiphospholipid antibody syndrome (D68.69) and 5 more.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Specific codes under D68.5
Coding notes
- Primary hypercoagulable states
- antiphospholipid syndrome (D68.61)
- lupus anticoagulant (D68.62)
- secondary activated protein C resistance (D68.69)
- secondary antiphospholipid antibody syndrome (D68.69)
- secondary lupus anticoagulant with hypercoagulable state (D68.69)
- secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
- systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
- systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
- thrombotic thrombocytopenic purpura (M31.19)
Notes that apply from higher levels
Instructions written at a parent level also apply to D68.5.
Broader instructions also apply from Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about D68.5
Is D68.5 billable?
- No. D68.5 is a header code. Report one of its more specific subcodes instead.